Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

• Main Authors: Grabowska, Joanna, Stolk, Dorian A., Nijen Twilhaar, M.K., Ambrosini, Martino, Storm, Gert, van der Vliet, Hans J., de Gruijl, Tanja D., Kooyk, Y., den Haan, Joke M. M.
• Other Authors: SURGERY
• Format: Article
• Published: MDPI AG 2022
• Subjects: Alpha galactosylceramide; Anti-tumor; CD169 macrophage; CDC1; Ganglioside GM3; Invariant natural killer T cell; Liposomes; Vaccination
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/233798
• Institution: National University of Singapore

10.3390/vaccines9010056